Whistleblower Lawsuit Over AstraZeneca Off-Label Marketing Ends in $2.4M Verdict
An Oregon jury wants AstraZeneca to pay $2.4 million for violating a former employee's whistleblower rights after she claimed the company was illegally marketing the asthma drug Symbicort.